Status:
RECRUITING
Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive Therapy
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
Neutropenia after induction or consolidation therapy for acute myeloid leukemia (AML) patients is associated with a high morbi-mortality rates, especially due to infectious complications. These are ma...
Detailed Description
This is the first prospective study on digestive affections in an homogeneous cohort of hematological patients. These affections are unknown in neutropenic patients with digestive symptoms after induc...
Eligibility Criteria
Inclusion
- Age \> 18 years
- inclusion criteria:
- Every patient of hematology:
- Able to receive an intensive treatment for AML (induction then intensive consolidations) causing a neutropenia with high infectious risk
- In state to give its consent
- Affiliated to a social security system
Exclusion
- The minor patients
- The patients affected by AML not being able to receive an intensive therapy
- The patients affected by acute promyelocytic leukaemia
- The pregnant women
- The patients with HIV, hepatitis B or C
- The patients under guardianship or guardianship or deprived of freedom by a court or administrative order (according to articles L1121-6 and L1121-8 of the Public health code)
Key Trial Info
Start Date :
January 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 13 2024
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT03450512
Start Date
January 14 2019
End Date
November 13 2024
Last Update
July 10 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens-Picardie
Amiens, France, 80000
2
CHU de Caen
Caen, France, 14033
3
Henri Becquerel Center
Rouen, France, 76038